Literature DB >> 29545339

The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.

Berdien E Oortgiesen1, Roshna Azad2, Marc H Hemmelder3, Robby E Kibbelaar4, Nic J G M Veeger5,6, Joost C de Vries7, Eric N van Roon8, Mels Hoogendoorn7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29545339      PMCID： PMC6029552          DOI： 10.3324/haematol.2017.184754

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  A population-based study of the impact of dialysis on mortality in multiple myeloma.

Authors:  Felicity Evison; Jason Sangha; Punit Yadav; Yu Sandar Aung; Adnan Sharif; Jennifer A Pinney; Mark T Drayson; Mark Cook; Paul Cockwell
Journal:  Br J Haematol       Date:  2016-10-21       Impact factor: 6.998

2.  Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study.

Authors:  Joost C de Vries; Berdien Oortgiesen; Marc H Hemmelder; Eric van Roon; Robby E Kibbelaar; Nic Veeger; Mels Hoogendoorn
Journal:  Leuk Lymphoma       Date:  2017-02-14

3.  Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.

Authors:  Alexandre Decourt; Bertrand Gondouin; Jean Christophe Delaroziere; Philippe Brunet; Marion Sallée; Stephane Burtey; Bertrand Dussol; Vadim Ivanov; Regis Costello; Cecile Couchoud; Noemie Jourde-Chiche
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-04       Impact factor: 8.237

4.  The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.

Authors:  M A Dimopoulos; M Roussou; M Gkotzamanidou; N Nikitas; E Psimenou; D Mparmparoussi; C Matsouka; M Spyropoulou-Vlachou; E Terpos; E Kastritis
Journal:  Leukemia       Date:  2012-07-05       Impact factor: 11.528

Review 5.  Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.

Authors:  Meletios A Dimopoulos; Evangelos Terpos; Asher Chanan-Khan; Nelson Leung; Heinz Ludwig; Sundar Jagannath; Ruben Niesvizky; Sergio Giralt; Jean-Paul Fermand; Joan Bladé; Raymond L Comenzo; Orhan Sezer; Antonio Palumbo; Jean-Luc Harousseau; Paul G Richardson; Bart Barlogie; Kenneth C Anderson; Pieter Sonneveld; Patrizia Tosi; Michele Cavo; S Vincent Rajkumar; Brian G M Durie; Jésus San Miguel
Journal:  J Clin Oncol       Date:  2010-10-18       Impact factor: 44.544

6.  The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

Authors:  Cécile Couchoud; Bénédicte Stengel; Paul Landais; Jean-Claude Aldigier; François de Cornelissen; Christian Dabot; Hervé Maheut; Véronique Joyeux; Michèle Kessler; Michel Labeeuw; Hubert Isnard; Christian Jacquelinet
Journal:  Nephrol Dial Transplant       Date:  2005-10-18       Impact factor: 5.992

7.  Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.

Authors:  J F San-Miguel; P G Richardson; P Sonneveld; M W Schuster; D Irwin; E A Stadtmauer; T Facon; J-L Harousseau; D Ben-Yehuda; S Lonial; H Goldschmidt; D Reece; J Bladé; M Boccadoro; J D Cavenagh; R Neuwirth; A L Boral; D-L Esseltine; K C Anderson
Journal:  Leukemia       Date:  2008-01-17       Impact factor: 11.528

Review 8.  Pathogenesis and treatment of renal failure in multiple myeloma.

Authors:  M A Dimopoulos; E Kastritis; L Rosinol; J Bladé; H Ludwig
Journal:  Leukemia       Date:  2008-06-05       Impact factor: 11.528

9.  Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.

Authors:  Dimitrios J Tsakiris; Vianda S Stel; Patrik Finne; Emily Fraser; James Heaf; Johan de Meester; Sabine Schmaldienst; Friedo Dekker; Enrico Verrina; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2009-12-27       Impact factor: 5.992

10.  Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014.

Authors:  M Laforet; N Jourde-Chiche; F Haddad; M Sallee; A M Stoppa; P Brunet; B Dussol; S Burtey; B Gondouin
Journal:  Blood Cancer J       Date:  2016-03-25       Impact factor: 11.037
View more
  1 in total

1.  Activation of ER Stress-Dependent miR-216b Has a Critical Role in Salviamiltiorrhiza Ethanol-Extract-Induced Apoptosis in U266 and U937 Cells.

Authors:  Changmin Kim; Hyo-Sook Song; Hojung Park; Bonglee Kim
Journal:  Int J Mol Sci       Date:  2018-04-19       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.